Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome

SIMPLE SUMMARY: Pancreatic neuroendocrine neoplasms (PanNENs) represent approximately 30% of all gastro-entero-pancreatic NENs. According to current knowledge, the association between PanNENs and metabolic syndrome (MS) is not known. The study aimed to assess the relationships between selected serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosiek, Violetta, Bocian-Jastrzębska, Agnes, Kos-Kudła, Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137194/
https://www.ncbi.nlm.nih.gov/pubmed/37190276
http://dx.doi.org/10.3390/cancers15082348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10137194/
https://www.ncbi.nlm.nih.gov/pubmed/37190276
http://dx.doi.org/10.3390/cancers15082348

Ejemplares similares